Preferred Networks to Launch “MN-1b” Private Sector Supercomputer Adopting NVIDIA Tesla V100 32GB GPUs
Preferred Networks, Inc. (PFN), a provider of IoT-centric deep learning systems, NTT Communications Corporation (NTT Com), the ICT solutions and international communications business within the NTT Group, and NTT Com subsidiary NTT PC Communications Incorporated (NTT PC) announced today that PFN will launch an expanded version of its MN-1 private sector supercomputer equipped with NTT Com and NTTPC’s next-generation GPU platform by July. The new MN-1b supercomputer will adopt the NVIDIA® Tesla® V100 32GB, that was announced at GTC 2018 on March 27, 2018 (U.S. time).
PFN plans to enhance MN-1 by adding 512 NVIDIA Tesla V100 32GB GPUs and have them up and running by July, with the added GPUs having a theoretical peak performance of about 56 PetaFLOPS1, a massive 56,000 trillion floating-point operations per second, based on a mixed precision floating-point operation2 used in deep learning. This means the expansion alone will contribute to a roughly threefold increase from the current peak.
PFN expects the new supercomputer’s extra high speed and massive processing environment leveraging the latest GPUs will accelerate the real-world applications of its research and development in deep learning and related technologies and thereby strengthen PFN’s global competitiveness. NTT Com and NTT PC will build and operate the multi-node platform leveraging the latest GPUs that meets PFN’s requirements, using their knowledge of intra-GPU communication and waste heat processing.
"We are truly honored that Preferred Networks has chosen NVIDIA Tesla V100 32GB, most advanced data center GPU with 2X the memory, for its next-generation private supercomputer’s computation environment, “MN-1b”. With NTT Com Group’s experience of establishing and managing highly reliable data center services, combined with NVIDIA’s latest high-speed GPUs for deep learning, we sincerely look forward to R&D results in the fields of transportation systems, manufacturing and biotech/healthcare," said Masataka Osaki, Vice President of Corporate Sales and NVIDIA Japan Country Manager.
Emmy Chang, Board Director, Supermicro KK and VP of Strategic Sales, Supermicro said, “Preferred Networks is the first in the world to deploy our SuperServer® 4029GP-TRT2 equipped with the latest version of Intel® Xeon® Scalable processors and supporting eight NVIDIA Tesla V100 32GB GPU accelerators,” “Preferred Networks has developed the world-class private supercomputer through cooperative work with NTT Com Group, and Supermicro continues to support them with our latest innovative hardware and solutions. We are confident that Preferred Networks will achieve new heights with its new private supercomputer.”
PFN will use the new MN-1b to raise the speed of its ChainerTM open source deep-learning framework and further accelerate its research and development in fields that require a huge amount of computing resources, namely transportation systems, manufacturing, bio-healthcare, and creativity.
Going forward, NTT Com expects to increasingly support the delivery of AI technologies and related platforms for advanced research and commercialized deep learning, including the AI business initiatives of PFN.
1 A unit measuring computer performance. Peta is 1,000 trillion (10 to the power of 15) and FLOPS is used to count floating-point operations per second. So, 1 PetaFLOPS means that a computer is capable of performing 1,000 trillion floating-point calculations per second.
2 Mixed precision floating-point operation is a method of floating point arithmetic operations with combination of multiple precisions.
ChainerTM is a trademark or a registered trademark of Preferred Networks, Inc. in Japan and other countries. Other company names and product names written in this release are the trademarks or the registered trademarks of each company.
About Preferred Networks, Inc.
Founded in March 2014 with the aim of promoting business utilization of
deep learning technology focused on IoT, PFN advocates Edge Heavy
Computing as a way to handle the enormous amounts of data generated by
devices in a distributed and collaborative manner at the edge of the
network, driving innovation in three priority business areas:
transportation, manufacturing and bio/healthcare. PFN develops and
provides Chainer, an open source deep learning framework. PFN promotes
advanced initiatives by collaborating with world leading organizations,
such as Toyota Motor Corporation, Fanuc Corporation and the National
About NTT Communications Corporation
NTT Communications provides consultancy, architecture, security and
cloud services to optimize the information and communications technology
(ICT) environments of enterprises. These offerings are backed by the
company’s worldwide infrastructure, including the leading global tier-1
IP network, the Arcstar Universal One™ VPN network reaching over 190
countries/regions, and over 140 secure data centers worldwide. NTT
Communications’ solutions leverage the global resources of NTT Group
companies including Dimension Data, NTT DOCOMO and NTT DATA.
www.ntt.com | Twitter@NTT Com | Facebook@NTT Com | LinkedIn@NTT Com
NTT PC Communications Incorporated
NTTPC Communications Incorporated (NTTPC), established in 1985 is a subsidiary of NTT Communications, is a network service and communication solution provider in Japanese telco market, The company has been the most strategic technology company of the group throughout of years. NTTPC launched the 1st ISP service of the NTT group, so called “InfoSphere” at 1995, and also launched the 1st Internet Data Center and server hosting services of Japan so called “WebARENA” at 1997. NTTPC have always started something new in ICT market.
Ms. Yuko Miyamoto, Ms. Aoi Funagoshi, +81 3 6700 4010
Corporate Planning Department
NTT PC Communications Incorporated
Mr. Sato, Mr. Hayashi, +81 50 3388 1664
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
XINHUANET: Promotion Event of The Most Beautiful Shooting Location in China Held During Cannes Film Festival25.5.2019 21:20:00 EEST | Tiedote
On May 16 (local time), an event was held at the 72nd Cannes Film Festival to recommend China’s most beautiful shooting locations on the theme of “Fascinating China.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190525005008/en/ The representative from Cannes Convention Bureau (1st L), Michel Chevillon (C), vice president of the French Riviera Chamber of Commerce and Industry and head of hotel association, and Adeline CHAUVEAU (3rd R), officer in charge of film and television projects from French Embassy to China, pose for a group photo with the representatives from the cities awarded for "The most beautiful shooting location in China." (Photo: Business Wire) In the event, the Yellow Sea National Forest Park in Dongtai, Jiangsu Province, the One Hundred Mile Azalea Forest in Bijie, Guizhou Province, Siming District of Xiamen, Fujian Province, and the Li Autonomous County in Lingshui, Hainan Province were on the list. The p
Knopp Biosciences Presents Positive Preclinical Data for Lead Neonatal Epilepsy Drug Candidate at 2019 Antiepileptic Drug and Device Trials XV Conference24.5.2019 17:00:00 EEST | Tiedote
Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases of high unmet need, today presented in vitro and in vivo data for the company’s lead molecule for the targeted treatment of KCNQ2-neonatal epileptic encephalopathy (KCNQ2-NEE) at the Antiepileptic Drug and Device Trials XV Conference in Miami, Florida. KCNQ2-NEE, a rare infant genetic epilepsy, results from mutations in genes encoding the Kv7.2/Kv7.3 ion channel, leading to frequent seizures and profound developmental delay. The preclinical data were presented by Steven Dworetzky, Ph.D., Knopp’s Chief Scientific Officer, a longtime Kv7 researcher who led the group that first cloned the Kv7.2 and Kv7.3 genes during his former tenure with the Bristol-Myers Squibb Co. Dr. Dworetzky presented results demonstrating the in vitro nanomolar activity of KB-3061 and its significant seizure protection in the maximal electroshock mo
Accelerate Your Business in South Korea Through 2019 K-Startup Grand Challenge24.5.2019 13:20:00 EEST | Tiedote
Entrepreneurs from across the globe should set their sights on participating in the 2019 K-Startup Grand Challenge. Supported by the Ministry of SMEs and Startups and National IT Industry Promotion Agency (NIPA) of South Korea, the initiative provides invaluable support and comprehensive resources to early age startups. Applications for the K-Startup Grand Challenge are currently being accepted through June 14, 2019. In order to advance in the program, teams must pass a regional audition. A judging panel of startup ecosystem experts and Korean accelerators will select 40 teams to participate in an enriching 3.5 month-long acceleration program in Korea. The selected teams will have exclusive access to free office space at the Startup Campus in Pangyo Techno Valley, one-on-one mentoring, information sessions, coaching on Korean and Asian business culture and the chance to attend insightful seminars on accounting regulations to tax laws, patents and more. Opportunities for networking with
New Investigational Clinical Data for Ipsen’s Oncology Products in 11 Solid Tumor Types to Be Presented at 2019 ASCO Annual Meeting24.5.2019 08:00:00 EEST | Tiedote
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that new data from clinical studies on investigational uses of cancer medicines cabozantinib (Cabometyx®), liposomal irinotecan (Onivyde®), and lanreotide autogel (Somatuline®, marketed as Somatuline Depot® in the United States) will be presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting takes place in Chicago, Illinois, U.S., 31 May–4 June 2019; data featuring Ipsen medicines includes: New data from the Phase 3 CELESTIAL trial on the association of adverse events with efficacy outcomes for cabozantinib in patients with advanced hepatocellular carcinoma Overview of the Phase 3 COSMIC-312 trial of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma who have not received previous systemic anticancer therapy First Phase 2 data from the CaboGIST study (trial 1317) from the European Organization for Research and Treatment of
The Posiflex Group Showcases an Ecosystem of Connected Solution Endpoints with IoT Remote Monitoring at Computex 201924.5.2019 04:00:00 EEST | Tiedote
For the Computex 2019 show, The Posiflex Group is featuring leading solution technology from the family of brands as a fully Serviced IoT Ecosystem. Solution end points include: Connected Modular Kiosks, POS Terminals, and Digital Signage solutions from Posiflex and KIOSK Information Systems Smart Medical Displays with gesture controls from Portwell Connected Gaming Solutions with Player Tracking Technology from Portwell subsidiary, Ganlot The booth display is based on common field service endpoints represented in a European Manor Destination Resort setting. Field solutions for an array of vertical market applications include QSR ordering, cinema ticketing, fashion retail customer loyalty, interactive signage, hotel / medical center check-in and bill pay, as well as casino gaming technology. This year, in addition to their renowned POS product suite, Posiflex will be featuring newly introduced Modular Kiosk platforms (co-designed by KIOSK and Posiflex), which are configure-to-order sta
Audi China President Thomas Owsianski to Keynote at CES Asia 201923.5.2019 23:00:00 EEST | Tiedote
The Consumer Technology Association (CTA)TM today announced that Thomas Owsianski, president of Audi China, will deliver a keynote address at the upcoming CES Asia 2019. Now in its fifth year, CES Asia will run June 11-13, 2019 at the Shanghai New International Expo Centre (SNIEC) in Shanghai, China. Thomas Owsianski’s keynote is scheduled for 4 PM, Tuesday, June 11, where he will unveil Audi’s vision in transforming mobility from a driving experience to a digital adventure. Mr. Owsianski joined the top management team of Audi China in August 2018 and was named President in October 2018. “Audi has been at the forefront of driving global transformation in the automotive industry through their breakthrough advancements in technology,” said Karen Chupka, executive vice president, CES. “Innovation has revolutionized the transportation experience, and we welcome Mr. Owsianski to the CES Asia stage to share Audi’s vision for the future of global mobility.” Throughout Asia and beyond, technol
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme